Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CSF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MORC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TAF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HCAR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JDP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBMX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930531 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF146 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VAMP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLRMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFHX4-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM181B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHB17P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on